Leica Biosystems
Washington, DC, US
Leica Biosystems is a global medical device and biotechnology company specializing in clinical diagnostics for the pathology market. They are focused on advancing cancer diagnostics and improving lives by providing comprehensive solutions across the entire pathology workflow, from biopsy to diagnosis.
How We Help
Problem Statement
Leica Biosystems addresses the challenge of providing integrated and efficient solutions across the entire pathology workflow, aiming to advance cancer diagnostics and improve diagnostic accuracy and speed for better patient outcomes.
Core Technology
Digital Pathology (including scanners, software, and AI store), Companion Diagnostics (CDx), Histology Solutions, Pre-Analytics & Specimen Processing, Cytogenetics Imaging Software, and advanced instruments and reagents.
Key Differentiators
Offers a comprehensive, end-to-end portfolio that integrates and optimizes all aspects of the anatomical pathology workflow, connecting departments, solutions, and processes across the cancer diagnosis pathway.
Clinical Focus
Cancer diagnostics
Target Customers
Clinical pathology laboratories, hospitals, and pharmaceutical companies.
Product Stage
Mature
Company Info
- Business Model
- B2B, providing solutions and technologies across the pathology workflow to laboratories, hospitals, and through partnerships for companion diagnostics with pharmaceutical companies.
- Founded
- 1984
- Website
- www.leicabiosystems.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Leica Biosystems?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.